Drug
PAC-14028 Cream 0.3%
PAC-14028 Cream 0.3% is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
4
80%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
NCT02748993
completedphase_2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729
completedphase_2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
NCT02583009
completedphase_2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus
NCT02565134
completedphase_2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
NCT02749383
Clinical Trials (5)
Showing 5 of 5 trials
NCT02748993Phase 1
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
NCT02757729Phase 2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02583009Phase 2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
NCT02565134Phase 2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus
NCT02749383Phase 2
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5